Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF

Clinical trial NCT04533022 · COMPLETED

Trial details

NCT number: NCT04533022
Sponsor: Vicore Pharma AB
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2020-11-13
Primary completion: 2024-03-30
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.